Atorvastatin Preserves Renal Function in Chronic Complete Unilateral Ureteral Obstruction

Journal of Urology

Volumn 177, Issue 2, 2007, Pages 781-785

  Michli, Eddie ^a   Gulmi, Frederick A ^a   Chou, Shyan Yih ^a   Mooppan, Unni M M ^a   Kim, Hong ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

albuminuria; atorvastatin; kidney; rats; Sprague Dawley; ureteral obstruction

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; URETER OBSTRUCTION; URINE LEVEL;

ANIMALS; CHRONIC DISEASE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FUNCTION TESTS; MALE; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; URETERAL OBSTRUCTION;

EID: 33845974926     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.09.078     Document Type: Article

References (20)

1. Klahr S., and Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283 (2002) F861
2. Wen J.G., Frokiaer J., Jorgensen T.M., and Djurhuus J.C. Obstructive nephropathy: an update of the experimental research. Urol Res 27 (1999) 29
3. Usui H., Shikata K., Matsuda M., Okada S., Ogawa D., Yamashita T., et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 18 (2003) 265
4. Elisaf M., and Mikhailidis D.P. Statins and renal function. Angiology 53 (2002) 493
5. Nakamura T., Ushiyama C., Hirokawa K., Osada S., Inoue T., Shimada N., et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. Nephrol Dial Transplant 17 (2002) 798
6. Liao J.K. Isoprenoids as mediators of the biological effects of statins. J Clin Invest 110 (2002) 285
7. Ota T., Takamura T., Ando H., Nohara E., Yamashita H., Kobayashi K., et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 46: (2003) 843
8. Harris K.P., Purkerson M.L., Yates J., and Klahr S. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 15 (1990) 16
9. Wassmann S., Laufs U., Baumer A.T., Muller K., Ahlbory K., Linz W., et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37: (2001) 1450
10. Sabbatini M., Pisani A., Uccello F., Serio V., Seru R., Paterno R., et al. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J Am Soc Nephrol 15 (2004) 901
11. Mizuguchi Y., Miyajima A., Kosaka T., Asano T., and Hayakawa M. Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol 172 (2004) 2456
12. Moriyama T., Kawada N., Nagatoya K., Takeji M., Horio M., Ando A., et al. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 59 (2001) 2095
13. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425
14. Vaughan C.J., Murphy M.B., and Buckley B.M. Statins do more than just lower cholesterol. Lancet 348 (1996) 1079
15. Krause B.R., and Newton R.S. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis 117 (1995) 237
16. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20 (1992) 1
17. Vaughan Jr. E.D., Marion D., Poppas D.P., and Felsen D. Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol 172 (2004) 2563
18. Imai E., Nakajima H., and Kaimori J.Y. Albumin turns on a vicious spiral of oxidative stress in renal proximal tubules. Kidney Int 66 (2004) 2085
19. Wolf G., Schroeder R., Ziyadeh F.N., and Stahl R.A. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Kidney Int 66 (2004) 1849
20. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59 (2001) 260